Risk factors associated with delay in diagnosis and mortality in patients with COVID-19 in the city of Rio de Janeiro, Brazil
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14284489
A
Alexandre de Fátima Cobre
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
1.2K
Citations
11
h-index
14
i10-index
Alexandre de Fátima Cobre is an academic researcher from University of Manchester. The author has contributed to research in topics: Computational Drug Discovery Methods & COVID-19 Clinical Research Studies & Metabolomics and Mass Spectrometry Studies. The author has an h-index of 11, co-authored 55 publications.
ORCID: 0000-0001-6642-3928Papers by this author
worksNaringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23616713
Advances in soft nanoparticle-based platforms for human and veterinary trichomoniasis therapy: A scoping review
2025 · European Journal of Pharmaceutics and Biopharmaceutics · 0 citations
https://doi.org/10.1016/j.ejpb.2025.114638
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat